Citius Oncology, Inc. · NASDAQ:CTOR

Armistice Capital, LLC reported a 9.79% stake in Citius Oncology, Inc. (Schedule 13G)

Event Sep 30, 2025 · Filed Nov 14, 2025

Armistice Capital, LLC reported a 9.79% stake in Citius Oncology, Inc., 7,675,911 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).

Stake
9.79%
Shares
7,675,911
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC9.79%7,675,911
Steven Boyd9.79%7,675,911

Source

View original at SEC

Related